GlassScriptPhysician profile
Thomas N Joseph
NPI 1003845629
$2,842.55
in general payments reported to CMS, 2019-2025
22 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $96.81 · 2021: $390 · 2022: $399 · 2023: $588 · 2024: $733 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258 · Travel and Lodging: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.81 |
| Travel and Lodging | $372.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $563.98 | 2019-2025 | Rigidloop, Twistr, N/A |
| Stryker Corporation | $383.18 | 2019-2023 | T2, Gamma |
| Medical Device Business Services, INC. | $372.76 | 2024 | Rigidloop |
| Sanara Medtech INC. | $340.58 | 2021-2023 | Fortify |
| Smith+Nephew, INC. | $209.02 | 2019-2025 | Grafix Pl, Evos |
| Zimmer Biomet Holdings, INC. | $188.03 | 2020-2024 | Persona, Tapestry |
| Abbott Laboratories | $149.12 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $141.10 | 2025 | |
| Janssen Pharmaceuticals, INC | $77.46 | 2021-2023 | Xarelto |
| Convatec INC. | $74.38 | 2023-2024 | |
| Fidia Pharma USA INC. | $72.25 | 2020-2025 | Hyalgan, Triluron, Hymovis |
| Amgen INC. | $66.92 | 2020-2025 | Krystexxa, Prolia, Evenity |
| Bioventus LLC | $46.55 | 2023-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Peerless Surgical INC. | $37.71 | 2025 | |
| Medtronic USA, INC. | $20.16 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $16.96 | 2023 | Zynrelef |
| Abbvie INC. | $16.53 | 2022 | |
| Acera Surgical, INC. | $15.52 | 2024 | Restrata Wound Matrix |
| Dynasplint Systems INC. | $13.51 | 2025 | Dynasplint |
| Orthogenrx INC. | $13.29 | 2019 | |
| Pfizer INC. | $12.70 | 2020 | |
| Osiris Therapeutics INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.